Wegovy Singapore 2026 — Why Semaglutide Works for Some People But Not Others

Wegovy, a brand name for Semaglutide, has rapidly become one of Singapore’s most in-demand prescription weight-loss injections. Patients often see significant appetite reduction, improved metabolic markers, and clinically meaningful weight loss. Yet an equally large group wonders:

“Why is Wegovy not working as well for me?”
or
“Why did I plateau after the first few months?”

This comprehensive Singapore-specific guide breaks down the real science behind Wegovy, why responses vary dramatically across individuals, who benefits the most, why weight loss sometimes stalls, and what factors predict long-term success.

It also explains how proper medical supervision, such as through clinics experienced in GLP-1 weight management (e.g., Nee Soon Clinic’s medically guided weight-loss injections), can significantly influence outcomes because the medication is only one part of the metabolic puzzle.

What Is Wegovy and How Does It Work?

Wegovy is a prescription medication containing Semaglutide, a GLP-1 receptor agonist originally developed for diabetes and now FDA-approved for chronic weight management. It works by mimicking the GLP-1 hormone involved in:

• Appetite regulation
• Gastric emptying
• Reward-based eating
• Blood sugar stabilization

Mechanisms supported by clinical research:

1. Reduced appetite and cravings

Wegovy signals “satiety” to the brain’s hypothalamus, helping patients feel full faster and stay full longer.

2. Slowed gastric emptying

Food leaves the stomach more slowly, keeping hunger at bay.

3. Improved insulin response

Which reduces glucose spikes and dips that trigger hunger.

4. Impact on reward pathways

Semaglutide may reduce compulsive eating by modulating dopamine-based food reward circuits.

While the mechanism is consistent, patient responses vary widely, which brings us to the central question:

Why do some people lose 15–20% of their body weight on Wegovy, while others lose far less?

Why Wegovy Works Better for Some People Than Others

Here, we analyze the nine evidence-backed reasons for variable outcomes with Wegovy, using findings from large-scale studies and clinical observations.

1. Genetic and metabolic differences

Research shows individuals respond differently to appetite-regulation signals based on:

• GLP-1 receptor sensitivity
• Baseline insulin resistance
• Mitochondrial efficiency
• Set-point theory of weight

Some bodies simply respond more strongly to GLP-1 signalling, while others require more time or dose adjustments.

2. Differences in microbiome composition

A growing body of research suggests the gut microbiome plays a role in:

• Satiety signals
• Inflammation
• Metabolic rate
• Blood glucose handling

Some bacterial profiles enhance GLP-1 drug responsiveness; others blunt it.

3. Starting metabolic health

Patients with:

• Higher visceral fat
• Fatty liver
• Severe insulin resistance
• PCOS
• Hypothyroidism

may take longer to see changes because the body’s hormonal environment is harder to shift.

4. Whether patients follow a structured nutrition plan

Although many believe Wegovy works “no matter what you eat,” clinical trials required:

• Calorie-appropriate meals
• Higher protein intake
• Reduced refined carbohydrates

Patients who continue high-calorie, high-reward food patterns may see blunted results.

Clinics offering guided plans — such as Nee Soon Clinic’s weight-loss injection program (which currently gives the best offer at S$360/pen) — often combine injection therapy with personalised nutrition, significantly improving outcomes.

5. Physical activity level

Wegovy boosts appetite control, but it does not directly increase metabolic rate.
Patients who remain sedentary may lose less weight compared to those who:

• Walk 8,000–10,000 steps daily
• Add twice-weekly strength training
• Improve NEAT (non-exercise activity thermogenesis)

Even small activity increases can break plateaus.

6. The presence of emotional or binge-eating patterns

Some patients overeat due to:

• Stress
• Habit
• Emotional triggers
• Reward-seeking

If these patterns persist, weight loss may plateau even with a lower appetite.

7. Incorrect dosing or interrupted treatment

Wegovy’s dosing schedule requires gradual escalation:

0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg maintenance

Some patients plateau due to:

• Staying too long on low doses
• Having to pause due to side effects
• Not reaching therapeutic dose

Experienced clinicians can help adjust dose timing.

8. Underlying medical conditions

Conditions associated with reduced responsiveness include:

• Cushing’s syndrome
• Hypothyroidism
• PCOS
• Depression medication classified as SSRIs/SNRIs
• Certain antipsychotics

These may counteract appetite-suppression effects.

9. Lifestyle environment

Factors like sleep deprivation, high stress, or irregular eating patterns dampen metabolic response and may override Wegovy’s appetite-signal improvements.

Why Wegovy Plateaus Happen — And How to Overcome Them

A common concern is:

“I lost weight at the beginning but now I’ve plateaued — why?”

Plateaus typically occur for scientifically predictable reasons.

1. Set-point theory adjusting

The brain has a “preferred weight range” shaped by:

• Hormones
• Evolutionary biology
• Historical weight patterns

As you lose weight, your body defends its set point by reducing metabolic burn.

2. Decreased NEAT

When appetite goes down, unintentional daily activity may also decrease.

Less movement → fewer calories burned → weight stalls.

3. Dose escalation not yet complete

Some patients plateau simply because they have not reached the therapeutic Wegovy dose.

4. Protein intake too low

GLP-1 patients often eat much less — but also eat less protein, which worsens muscle loss.
This reduces metabolic rate and slows fat loss.

5. Hidden calorie creep

Examples:

• Extra coffee creamers
• Sugar-sweetened drinks
• Night snacking
• Eating out frequently

Even with Wegovy, caloric surplus blocks progress.

6. Hormonal or thyroid issues

If weight loss is unusually slow, clinicians may order:

• Thyroid function tests
• Insulin resistance markers
• Cortisol panels
• Liver function tests

This ensures underlying issues aren’t masking progress.

Singapore Context: Who Should Consider Wegovy?

Wegovy is best suited for adults with:

• BMI ≥ 30
• BMI ≥ 27 with a weight-related condition (e.g., high BP, diabetes, sleep apnea)
• Struggles with appetite control
• History of yo-yo dieting

Singapore’s Health Sciences Authority (HSA) requires doctor supervision, meaning you cannot obtain Wegovy without a consultation and medical suitability check.

Wegovy (Semaglutide) at Nee Soon Clinic Singapore

As part of medically supervised weight-loss care, Nee Soon Clinic provides guidance on:

• Whether Wegovy is appropriate
• Baseline blood work
• Monitoring for side effects
• Dose titration
• Plateaus and metabolic adjustments
• Long-term lifestyle support

Their structured approach is designed to complement Wegovy’s effects rather than relying on the injection alone. At $360/pen they give the best price for a medical clinic in Singapore.

FAQs — WEGOVY IN SINGAPORE

1. Why does Wegovy work for some people but not others?

Response varies due to:

• Genetic GLP-1 sensitivity — some have naturally lower GLP-1 receptor density; the drug is less effective
• Baseline blood sugar control — diabetics and pre-diabetics see bigger weight loss (20%+); metabolically healthy people lose less (10-15%)
• Gut health — poor microbiota reduces appetite suppression and metabolic benefits
• Lifestyle adherence — Wegovy + proper diet/exercise = 20% loss; Wegovy alone = 10-15% loss
• Medication interactions — other drugs may interfere with semaglutide efficacy
• Plateau timing — most people plateau after 6-12 months; some continue losing if they adjust dose or lifestyle

Non-responders (lose <5%) are rare (5-10% of users); most people see some benefit.

2. How much weight will I lose on Wegovy?

Average loss:

• Responders: 15-22% body weight (e.g., 100kg → 78-85kg)
• Moderate responders: 10-15% body weight
• Slow responders: 5-10% body weight
• Non-responders: <5% (rare; 5-10% of users)

Timeline: Most weight loss occurs in first 6-12 months; then plateaus. Continued loss requires higher doses, lifestyle adjustments, or combination with other medications.

3. Can I stay on Wegovy long-term?

Yes. Clinical trials show safety for up to 2 years. Many doctors recommend maintenance dosing after weight loss plateau—continuing a lower dose to prevent weight regain. However, long-term safety beyond 2 years is still being studied.

4. What causes Wegovy plateaus?

Common reasons:

• Dose ceiling — your body adapts; dose escalation may not help further
• Poor adherence — inconsistent injections or diet slips reduce effectiveness
• Metabolic adaptation — your body’s calorie burn decreases as weight drops (normal)
• Thyroid or metabolic issues — undiagnosed conditions block further loss
• GLP-1 resistance — your body’s GLP-1 sensitivity diminishes over time
• Inadequate lifestyle — Wegovy alone isn’t enough; diet/exercise matter

Solutions: diet optimization, exercise intensification, dose adjustment, or combination with other medications.

5. Does Wegovy stop working after weight loss?

Partially. Most weight regain occurs within 1 year of stopping Wegovy (50-75% of lost weight returns). This is normal—your appetite signals return to baseline. Continuing at a maintenance dose (lower than peak) typically prevents regain.

6. What are side effects and how do I minimize them?

Common (manageable):

• Nausea (usually first 1-2 weeks)
• Vomiting or diarrhea
• Constipation
• Fatigue
• Dehydration

Serious (rare):

• Pancreatitis
• Gallbladder issues
• Thyroid concerns (if family history)
• Severe dehydration

Minimization: Start low dose, escalate slowly, stay hydrated, eat small frequent meals, avoid high-fat foods during nausea phase.

A NOTE FROM GAIA GUIDES

Wegovy is a powerful tool for weight loss, but it’s not magic and doesn’t work equally for everyone. If you’re considering Wegovy, have realistic expectations based on your individual factors: metabolic health, genetics, and lifestyle commitment. Those expecting 30% weight loss will be disappointed; those expecting 15% will be pleased. Work with a doctor experienced in semaglutide to identify your responder profile and optimize your protocol.

For more information on weight loss injections in Singapore: https://www.neesoonclinic.sg/weight-loss-injection

Or read up about Mounjaro Singapore: 2026 Price Guide, How It Works & Practical Comparison With Other Weight-Loss Options to find out how its different from Wegovy